GL1X · GenesisL1 explorer

MolNFT v1 · #101563 · protein

C50A mutant of synechococcus vkor, C2 crystal form (dehydrated)

4NV5 · VKORC1/THIOREDOXIN domain protein: “C50A mutant of synechococcus vkor, C2 crystal form (dehydrated)”. X-ray diffraction, 1 ligand (U10), 5 pockets (best druggability 0.78). MolNFT v1 #101563 on GenesisL1: 3D structure, binding sites…

PDB
4NV5
Type
protein
Length
521 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
VKORC1/THIOREDOXIN domain protein
UniProt
Q2JJF6
Ligands
U10
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 62% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVKORC1/THIOREDOXIN domain proteinprotein25962% helix, 7% strandQ2JJF6
BVKORC1/THIOREDOXIN domain proteinprotein26262% helix, 7% strandQ2JJF6

Ligands and binding sites

  • U10 · Ubiquinone-10 · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.780.9038U10
23050.750.8745U10
32120.530.7725empty
41550.510.7922empty
51360.510.7922empty

Interfaces

1 interface between chains.

  • A–B · 450 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 4NV5 · C50A mutant of Synechococcus VKOR, C2 crystal form (dehydrated) · the same entry in another collection · chain A against A, TM-score 1.00
  • Q2JJF6 · AlphaFold monomer V2.0 prediction for vitamin K epoxide reductase homolog (Q2JJF6) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.